167 related articles for article (PubMed ID: 29471123)
1. Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting.
Rodríguez-Fanjul V; López-Torres E; Mendiola MA; Pizarro AM
Eur J Med Chem; 2018 Mar; 148():372-383. PubMed ID: 29471123
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic and electrochemical characterization of gold(I) and gold(III) complexes with glyoxaldehyde bis(thiosemicarbazones): cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Ferraz KS; Guerra JC; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Barbeira PJ; Beraldo H
Biometals; 2012 Jun; 25(3):587-98. PubMed ID: 22526562
[TBL] [Abstract][Full Text] [Related]
3. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
[TBL] [Abstract][Full Text] [Related]
4. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
6. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
[TBL] [Abstract][Full Text] [Related]
8. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
9. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion.
Warżajtis B; Glišić BĐ; Savić ND; Pavic A; Vojnovic S; Veselinović A; Nikodinovic-Runic J; Rychlewska U; Djuran MI
Dalton Trans; 2017 Feb; 46(8):2594-2608. PubMed ID: 28155927
[TBL] [Abstract][Full Text] [Related]
10. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G
ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650
[TBL] [Abstract][Full Text] [Related]
11. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
Cheng Y; Qi Y
Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
[TBL] [Abstract][Full Text] [Related]
12. Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes.
Akladios FN; Andrew SD; Parkinson CJ
J Biol Inorg Chem; 2016 Jun; 21(3):407-19. PubMed ID: 26951232
[TBL] [Abstract][Full Text] [Related]
13. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
[TBL] [Abstract][Full Text] [Related]
14. SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer.
Lu Y; Sheng X; Liu C; Liang Z; Wang X; Liu L; Wen Z; Yang Z; Du Q; Liu W
Pharmacol Res; 2023 Apr; 190():106731. PubMed ID: 36933755
[TBL] [Abstract][Full Text] [Related]
15. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
16. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
Abyar F; Tabrizi L
Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
[TBL] [Abstract][Full Text] [Related]
17. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
18. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
19. N(4)-tolyl-2-acetylpyridine thiosemicarbazones and their platinum(II,IV) and gold(III) complexes: cytotoxicity against human glioma cells and studies on the mode of action.
Ferraz KS; Da Silva JG; Costa FM; Mendes BM; Rodrigues BL; dos Santos RG; Beraldo H
Biometals; 2013 Oct; 26(5):677-91. PubMed ID: 23749148
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
Bian M; Wang X; Sun Y; Liu W
Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
